YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

This study has been terminated.

Study NCT00050297 Information provided by Astellas Pharma Inc

First Received: December 3, 2002 Last Updated: March 31, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given